Xpreza

Xpreza Description

azacitidine

Manufacturer:

Natco Pharma

Distributor:

Natco Lifesciences
Full Prescribing Info
Description
The sterile single-use vial contains azacitidine 100 mg and mannitol 100 mg.
Azacitidine for Injection is supplied in a sterile form for reconstitution as suspension for subcutaneous injection or reconstitution as a solution with further dilutions for intravenous infusion. Vials of Azacitidine for Injection contain 100 mg of azacitidine and 100 mg of mannitol as a sterile lyophilized powder.
Excipients/Inactive Ingredients: Mannitol.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in